UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital
Go back to UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth CapitalLIGAND PHARMA (NASDAQ: LGND) | Delayed: 69.89 +1.36 (1.98%) | |||||
---|---|---|---|---|---|---|
Previous Close | $68.53 | 52 Week High | $139.79 | |||
Open | $68.50 | 52 Week Low | $82.07 | |||
Day High | $71.16 | P/E | 162.53 | |||
Day Low | $68.50 | EPS | $0.43 | |||
Volume | 140,672 |